Does transthyretin function as one of contributors for preeclampsia?

Medical Hypotheses

Volumn 76, Issue 1, 2011, Pages 8-10

  Chen, Yuxuan ^a   Zhang, Zhenyu ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; PREALBUMIN;

AMYLOIDOSIS; ARTICLE; DISEASE ASSOCIATION; HUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PREECLAMPSIA;

FEMALE; HUMANS; PRE-ECLAMPSIA; PREALBUMIN; PREGNANCY; RISK FACTORS;

EID: 78650171304     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2010.08.017     Document Type: Article

References (30)

1. Grill Simon, Rusterholz Corinne, Zanetti-Dällenbach Rosanna, Tercanli Sevgi, Holzgreve Wolfgang, Hahn Sinuhe, et al. Potential markers of preeclampsia - a review. Reprod Biol Endocrinol 2009, 23(7):70.
2. Cunningham F.Gary william'a obstetrics 2001, Prentice-hall International, Inc., USA. 20th ed.
3. Sep Simone, Smits Luc, Prins Martin, Peeters Louis Prediction tests for recurrent hypertensive disease in pregnancy, a systematic review. Hypertension in Pregnancy 2010, 29(2):206-230.
4. Schussler G.C. The thyroxine-binding proteins. Thyroid 2000, 10(2):141-149.
5. Mckinnon B., Li H., Richard K., Mortimer R. Synthesis of thyroid hormone binding proteins transthyretin and albumin by human trophoblast. J Clin Endocrinal Metab 2005, 90(12):6714-6720.
6. Luke Wiseman R., Powers Evan T., Kelly Jeffery W. Partitioning conformational intermediates between competing refolding and aggregation pathways: insights into transthyretin amyloid disease. Biochemistry 2005, 44(50):16612-16623.
7. Macedo Bárbara, Rita Batista Ana, Barbas do Amaral José, João Saraiva Maria Biomarkers in the assessment of therapies for familial amyloidotic polyneuropathy. Mol Med 2007, 13(11-12):584-591.
8. Bonaïti B., Olsson M., Hellman U., Suhr O., Bonaïti-Pellié C., Planté-Bordeneuve V. TTR familial amyloid polyneuropathy: does a mitochondrial polymorphism entirely explain the parent-of-origin difference in penetrance?. Eur J Hum Genet 2010, [Epub ahead of print].
9. Jacobson Daniel R., Gorevic Peter D., Buxbaum Joel N. A homozygous transthyretin variant associated with senile systemic amyloidosis: evidence for a late-onset disease of genetic etiology. Am J Hum Genet 1990, 47:127-136.
10. Kholova' I., Niessen H.W.M. Amyloid in the cardiovascular system: a review. J Clin Pathol 2005, 58:125-133.
11. Saraiva M.J. Transthyretin mutations in hyperthyroxinemia and amyloid diseases. Hum Mutat 2001 Jun, 17(6):493-503.
12. Hughes Siân E., McKenna William J. New insight into the pathology of inherited cardiomyopathy. Heart 2005, 91:257-264.
13. Reixach Nata' lia, Deechongkit Songpon, Jiang Xin, Kelly Jeffery W., Buxbaum Joel N. Tissue damage in the amyloidoses: transthyretin monomers, nonnative oligomers are the major cytotoxic species in tissue culture. Proc Natl Acad Sci 2004, 101(9):2817-2822.
14. Lavatelli Francesca, Perlman David H., Spencer Brian, Prokaeva Tatiana, McComb Mark E., Théberge Roger, et al. Amyloidogenic, associated proteins in systemic amyloidosis proteome of adipose tissue. Mol Cell Proteomics 2008, 7(8):1570-1583.
15. Schweigert Florian J., Wirth Kerstin, Raila Jens Characterization of the microheterogeneity of transthyretin in plasma and urine using SELDI-TOF-MS immunoassay. Proteome Science 2004, 2:1-6.
16. Kieninger B., Eriksson M., Kandolf R., Schnabel P.A., Schönland S., Kristen A.V., et al. Amyloid in endomyocardial biopsies. Virchows Arch 2010, [Epub ahead of print].
17. Nakagawa Kazuma, Sheikh Sarah I., Snuderl Matija, Frosch Matthew P., Greenberg Steven M. A new Thr49Pro transthyretin gene mutation associated with leptomeningeal amyloidosis. J Neurol Sci 2008, 272:186-190.
18. Gruys E., Toussaint M.J.M., Niewold T.A., Koopmans S.J. Acute phase reaction and acute phase proteins. J Zhejiang Univ SCI 2005, 6B(11):1045-1056.
19. Gericke Beate, Raila Jens, eja Maria, Sascha Rohn D., Donaubauer Bernd, Nagl Britta, et al. Alteration of transthyretin microheterogeneity in serum of multiple trauma patients. Biomark Insights 2007, 2:299-306.
20. Redman Christopher.W.G., Sacks Gavin P., Sargent Ian L. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999, 180:499-506.
21. Hacker Neville F., Gambone Joseph C., Hobel Calvin J. Hacker and Moore's essentials of obstetrics and gynecology 2010, SUNDERS. 5th ed.
22. Vascotto C., Salzano A.M., D'Ambrosio C., Fruscalzo A., Marchesoni D., di Loreto C., et al. Oxidized transthyretin in amniotic fluid as an early marker of preeclampsia. J Proteome Res 2007, 6(1):160-170.
23. Almeida V.M., Costa P.M., Moreira P., Gonçalves J., Braga J. Birth of two healthy females after preimplantation genetic diagnosis for familial amyloid polyneuropathy. Reprod Biomed Online 2005, 10(5):641-644.
24. Gilbert Jeffrey S., Nijland Mark J., Knoblich Penny Placental ischemia, cardiovascular dysfunction in preeclampsia, beyond: making the connections. Expert Rev Cardiovasc Ther 2008, 6(10):1367-1377.
25. Kolialexi Aggeliki, Anagnostopoulos Athanasios K., Mavrou Ariadni, Tsangaris George Th. Application of proteomics for diagnosis of fetal aneuploidies and pregnancy complications. Proteomics 2009, 72(5):731-739.
26. Verrills Nicole M. Clinical proteomics: present, future prospects. Clin Biochem Rev 2006, 27(2):99-116.
27. Almeida Maria Rosário, Macedo Bárbara, Cardoso Isabel, Alves Isabel, Valencia Gregorio, Arsequell Gemma, et al. Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative. Biochem J 2007, 381(Pt 2):351-356.
28. Johnson Steven M., Connelly Stephen, Wilson Ian A., Kelly Jeffery W. Toward optimization of the second aryl substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies. J Med Chem 2008, 51(20):6348-6358.
29. Johnson Steven M., Connelly Stephen, Wilson Ian A., Kelly Jeffery W. Toward optimization of the second aryl substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies. J Med Chem 2009, 52(4):1115-1125.
30. Mairal Teresa, Nieto Joan, Pinto Marta, Rosá rio Almeida Maria, Gales Luis, Ballesteros Alfredo, et al. Iodine atoms: a new molecular feature for the design of potent transthyretin fibrillogenesis inhibitors. PLoS ONE 2009, 4(1):e4124.